Market Signal Briefing

Analyst’s Disclosure: I/we have a beneficial long position in the shares of AMZN, GOOGL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Alphabet NASDAQ: GOOGL, the world's second-largest public company, once again delivered a standout earnings report, all but reinforcing its dominance across search, cloud, and artificial intelligence.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Adecco (AHEXY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Covergirl makeup, owned by Coty Inc., is seen for sale in Manhattan, New York City, U.S., February 7, 2022. REUTERS/Andrew Kelly Purchase Licensing Rights, opens new tab

SummaryCompaniesNew CEO Strobel says Coty's performance over past 18 months has been disappointingCoty sees Q3 core profit below estimates, with a 200-300 bps drop in gross marginReports Q2 revenue slightly above expectationsNet debt-to-adjusted core earnings ratio reaches nine-year lowFeb 5 (Reuters) - CoverGirl owner Coty (COTY.N), opens new tab withdrew its full-year guidance on Thursday as it launched a strategic focus on core brands, with new interim CEO Markus Strobel calling for improved discipline and execution to turn around sluggish financial performance.

Strobel, a Procter & Gamble veteran who took over from Sue Nabi on January 1, faces a tough challenge to revive sales, particularly in Coty's consumer cosmetics division, as competition from newer beauty brands and larger rivals such as L'Oréal (OREP.PA), opens new tab intensifies.

The Week in Breakingviews newsletter offers insights and ideas from Reuters' global financial commentary team. Sign up here.

Coty's shares were down about 7% after the bell. They have fallen by around 73% in the past two years.

Coty stock has underperformed the broader S&P 500 index and rivalsThe company was already concentrating efforts towards its prestige fragrances, initiating a strategic review in September of its consumer beauty division, which could lead to the sale of brands such as CoverGirl and Rimmel, but Strobel is now demanding even sharper focus.

CEO RUES 'DISAPPOINTING' FINANCIAL PERFORMANCE"Our financial performance over the past year and a half has been disappointing, and our current share price reflects that reality," Strobel said in a statement. "Coty has outstanding assets and capabilities, yet we have not been delivering at the level we should."

Coty reported a 0.5% year-on-year increase in net revenue for its second quarter, ended December 31, to $1.68 billion, slightly above analysts' expectations, but said it was anticipating Q3 gross margins to decline by 200 to 300 basis points from the year-ago period.

With advertising spending planned to reignite market share improvement, Coty expects third-quarter adjusted EBITDA to fall to $100-$110 million, well below analysts' average forecast of $201.6 million in core earnings for that quarter.

The strategic shift — named "Coty. Curated" — is about reducing complexity, CFO Laurent Mercier told Reuters, instilling a "less is more" mindset to drive core businesses and focus on key icons.

"We are going to select ... the big ones where we have great assets, where we know that we have the winners, and really reallocate this money on these assets."

Mercier highlighted Kylie Cosmetics, which has doubled in size in the past three years, as well as long-term licences with Burberry and Marc Jacobs as some of Coty's best assets.

DEBT AND LEVERAGE AT NINE-YEAR LOWSThe new plan may result in a leaner Coty. One for the chop is its licence with biotech-led skincare brand Orveda, co-founded by Coty's former CEO Nabi, as the company focuses on "scale, reach and profitability."

Coty sold its remaining 25.8% stake in hair care brand Wella to KKR (KKR.N), opens new tab for $750 million in December, using most of the proceeds to pay down long-term debt. The company's net debt to adjusted core earnings (EBITDA) ratio has now reached a nine-year low of 2.7x.

Coty said it may receive additional proceeds from an initial public offering of Wella, which sources told Reuters could happen in the U.S. as soon as this year.

Other headwinds remain. Coty is losing its exclusive Gucci fragrance and beauty licence in 2028 after Kering (PRTP.PA), opens new tab agreed to sell its beauty business to L'Oréal and ever more inflation-conscious shoppers are turning to affordable cosmetic brands such as Elf Beauty (ELF.N), opens new tab.

​

Reporting by Neil J Kanatt in Bengaluru and Alexander Marrow in London; Editing by Alan Barona

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Alexander covers European consumer goods from London, focusing on the corporate strategies of companies including Nestle, Unilever, Danone and Reckitt, as well as on how their products impact consumers’ daily lives. Alexander previously covered Russia’s economy and companies from Moscow, reporting on the fallout from Russia’s 2022 invasion of Ukraine and the Western corporate exodus that followed.

Fourth-quarter bookings surged 63% from a year earlier, while daily active users increased 69%, and the number of hours engaged jumped 88%.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of IGLTF, URTH, CHF:USD, GLD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Kindly note that our content on Seeking Alpha and other platforms doesn't constitute financial advice. Instead, we set the tone for a discussion panel among subscribers. As such, we encourage you to consult a registered financial advisor before committing capital to financial instruments.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

New York, New York--(Newsfile Corp. - February 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bath & Body Works, Inc. (NYSE: BBWI) between June 4, 2024 and November 19, 2025, both dates inclusive (the "Class Period"), of the important March 16, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Bath & Body Works securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Bath & Body Works class action, go to https://rosenlegal.com/submit-form/?case_id=50622 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 16, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements, and that defendants failed to disclose that: (1) Bath & Body Works' strategy of pursuing "adjacencies, collaborations and promotions" was not growing the customer base and/or delivering the level of growth in net sales touted; (2) as Bath & Body Works' strategy of "adjacencies, collaborations and promotions" faltered, it relied on brand collaborations "to carry quarters" and obfuscate otherwise weak underlying financial results; (3) as a result, Bath & Body Works was unlikely to meet its own previously issued financial guidance; and (4) as a result of the foregoing, defendants' positive statements about Bath & Body Works' business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Body & Body Works class action, go to https://rosenlegal.com/submit-form/?case_id=50622 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282928

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Regis Corporation (RGS) Q2 2026 Earnings Call February 5, 2026 8:30 AM EST

Company Participants

Kersten Zupfer - Executive VP & CFO
Jim Lain - Interim President, CEO and EVP of Brand Operations for Supercuts & Cost Cutters

Conference Call Participants

William Charters - Sabal Capital Management, LLC

Presentation

Kersten Zupfer
Executive VP & CFO

Good morning, and thank you for joining the Regis Second Quarter 2026 Earnings Conference Call. I am your host, Kersten Zupfer, Executive Vice President and Chief Financial Officer. I am joined today by our Interim Chief Executive Officer, Jim Lain. [Operator Instructions] And this conference is being recorded.

I would like to remind everyone that the language on forward-looking statements included in our earnings release and 8-K filing also applies to our comments made on the call today. These documents can be found on our website, www.regiscorp.com/investor-relations. We will be taking questions at the end of the call. Please use the Q&A feature to submit any questions.

With that, I will now turn the call over to Jim Lain.

Jim Lain
Interim President, CEO and EVP of Brand Operations for Supercuts & Cost Cutters

Good morning, everyone, and thank you for joining us for Regis Corporation's Second Quarter Fiscal 2026 Earnings Call. As I mentioned last quarter, our focus remains on building a more durable, modern and disciplined Regis, one that is positioned to sustain consistent cash generation, improve financial performance and create long-term value for all stakeholders. Q2 represents continued progress on that journey. We are operating with greater precision and sharpening our focus on the execution levers that matter most despite traffic headwinds across the system.

For the second quarter, adjusted EBITDA was $8 million, an increase of $900,000 year-over-year, driven by continued G&A discipline and contributions from our company-owned salon portfolio. Year-to-date adjusted EBITDA of $16 million is up $1.2

Q4: 2026-02-05 Earnings SummaryEPS of $0.19 beats by $0.04

 |

Revenue of

$92.50M

beats by $5.24M

Bullish (BLSH) Q4 2025 Earnings Call February 5, 2026 8:30 AM EST

Company Participants

Michael Fedele - Vice President of Finance
Thomas Farley - CEO & Chairman
David Bonanno - Chief Financial Officer

Conference Call Participants

Owen Lau - Clear Street LLC
Brian Bedell - Deutsche Bank AG, Research Division
Rayna Kumar - Oppenheimer & Co. Inc., Research Division
Madeline Daleiden - JPMorgan Chase & Co, Research Division
Peter Christiansen - Citigroup Inc., Research Division
Gareth Gacetta - Cantor Fitzgerald & Co., Research Division
Joseph Vafi - Canaccord Genuity Corp., Research Division
Edward Engel - Compass Point Research & Trading, LLC, Research Division
Christopher Brendler - Rosenblatt Securities Inc., Research Division

Presentation

Operator

Thank you for standing by. At this time, I would like to welcome everyone to the Bullish Global Fourth Quarter 2025 Earnings Call and Q&A. [Operator Instructions]

I would now like to turn the call over to Michael Fedele, Vice President of Finance. You may begin.

Michael Fedele
Vice President of Finance

Good morning, and welcome to our fourth quarter earnings call. I'm Michael Fedele, Vice President of Finance, and I'm joined on today's call by our Chief Executive Officer, Tom Farley; Chief Financial Officer, David Bonanno; and Director of Corporate Development, Liam Foley.

This call will contain forward-looking statements, including those relating to our expected performance and business opportunities. These statements are not assurances of future performance. They are subject to risks and uncertainties and our actual results could differ materially. For more details on these risks, please refer to today's earnings press release and our SEC filings, including our prospectus dated August 12, 2025. We undertake no obligation to update or revise any forward-looking statements.

This call will also include a discussion of non-IFRS financial measures. A reconciliation of these metrics to the most directly comparable IFRS metrics can be found in our earnings

The social media company posted a quarterly profit of $252 million, up from $71 million a year earlier.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses in Wealthfront to Contact Him Directly to Discuss Their Options

If you suffered significant losses in Wealthfront stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - February 5, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Wealthfront Corporation ("Wealthfront" or the "Company") (NASDAQ: WLTH).

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

Shares of Wealthfront Corporation declined sharply following the company's first post-IPO earnings release, pressured by disappointing asset flow figures and emerging investor concerns about strategic exposures underpinning its mortgage business. The stock sell-off came as Wealthfront reported softer net inflows in recent months, signaling a slowdown in client acquisitions and cash management balances relative to prior periods. Additionally, heightened market scrutiny over the CEO's ownership stake in a banking partner central to the firm's mortgage initiative has added to investor uncertainty, fueling speculation around potential conflicts of interest and long-term integration risks.

Since the company's IPO on or around December 12, 2025, at $14.00 per share, the stock has fallen $3.74, or 26.71%, to close at $10.26 on January 14, 2026.

To learn more about the Wealthfront investigation, go to www.faruqilaw.com/WLTH or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282884

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Viral social media trend spotlights America's fiber gap, fiber's role in long-term health, and its importance for people using GLP-1 medications

, /PRNewswire/ -- Life Time (NYSE: LTH), the nation's premier healthy lifestyle brand, is weighing in on "fibermaxxing," a growing social media trend encouraging people to increase their daily fiber intake to support health, longevity and overall metabolic well-being.

With fewer than 5 percent of Americans consistently meeting recommended daily fiber intake of 21–25 grams for women and 30–38 grams for men, the hashtag #fibermaxxing has garnered millions of views on TikTok. The trend reflects growing interest in gut health, balanced nutrition and sustainable eating habits across generations. With fewer than 5 percent of Americans consistently meeting recommended daily fiber intake of 21–25 grams for women and 30–38 grams for men, the hashtag #fibermaxxing has garnered millions of views on TikTok. The trend reflects growing interest in gut health, balanced nutrition and sustainable eating habits across generations.

Interest in fiber comes at a time when more Americans are using GLP-1 weight-loss medications, prompting renewed focus on how fiber and protein work together to support digestion, meal satisfaction, and long-term nutritional balance.

While fibermaxxing has gained traction among younger audiences, fiber intake is increasingly top-of-mind for adults over 40 and 50 as well, driven by attention from longevity experts, wellness podcasts and preventive-health clinicians.

"Fiber plays an essential role in overall health and is especially vital for healthy aging," said James LaValle, Life Time Chief Science Officer and Clinical Pharmacist, C.C.N.M.T., C.C.N. "Adequate fiber intake supports blood sugar balance, gut health and hormone metabolism, as well as promoting fullness. Together, these can strongly influence health span. For most people, meaningful improvement starts with adding one or two quality fiber sources a day."

The Metabolic Code bloodwork assessment offered through MIORA at Life Time further highlights how common digestive and metabolic imbalances are, and how modest increases in daily fiber can support long-term health improvements.

"Unlike many recent nutrition trends, fibermaxxing is additive, which makes it generally positive," said Paul Kriegler, Registered Dietitian and Senior Director of Nutritional Products at Life Time. "Most adults aren't getting enough fiber and increasing intake can support digestion, appetite control, and overall health."

The two main types of fibers are soluble and insoluble fiber. Soluble fiber is found in foods like oats, beans, apples, citrus fruits, and chia seeds, which dissolves in water and helps regulate blood sugar and cholesterol. Insoluble fiber is often found in vegetables, whole grains, nuts, and seeds, which add bulk and support regular digestion. Kriegler notes that fiber can also complement adequate protein intake, particularly for individuals using GLP-1 medications, where digestive comfort and balanced nutrition are especially important.

Kriegler also sees the trend as part of a broader shift in how younger generations approach health. "The current social media generation seems to care about their health earlier and more proactively," he said. "Choosing more natural sources of protein and fiber is a very positive movement. Ample protein and ample produce tend to create healthier people."

How to increase fiber without feeling miserable:
Kriegler emphasizes that the most common mistake people make with fibermaxxing is increasing intake too quickly. His recommendations include:

Build up gradually: Increase fiber slowly over several weeks to allow your digestive system to adapt. Drink enough water: Fiber works best when paired with adequate hydration. Prioritize whole foods: The best sources of fiber are vegetables, fruits, beans, lentils, and whole grains. Be consistent, not perfect: Adding one high-fiber item to each meal is more sustainable than changing everything at once. Use supplements when helpful: Fiber powders are a practical, convenient tool for consistency when whole-food intake falls short. Life Time supports nutrition improvement through programs and services that include nutrition coaching, fiber-focused programs such as its 14-day reset called D.TOX, training, and access to its LTH supplement line, including LTH Shift Fiber, a prebiotic fiber powder designed to support digestive health and daily consistency.

For more information about Life Time, visit www.lifetime.life, follow on social media at Facebook, Instagram and LinkedIn, or download the complimentary Life Time App.  

About Life Time
Life Time (NYSE: LTH) empowers people to live healthy, happy lives through its more than 185 athletic country clubs across the U.S. and Canada, the complimentary and comprehensive Life Time app featuring its L•AI•C™ AI-powered health companion, and more than 30 iconic athletic events. Serving people ages 90 days to 90+ years, the Life Time ecosystem uniquely delivers healthy living, healthy aging, and healthy entertainment experiences, a range of unique healthy way of life programs, highly trusted LTH nutritional supplements and more. Recognized as a Great Place to Work®, the company is committed to upholding an exceptional culture for its 43,000 team members.

SOURCE Life Time, Inc.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered in Vistagen to Contact Him Directly to Discuss Their Options

If you purchased or acquired securities in Vistagen between April 1, 2024 and December 16, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - February 5, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Vistagen Therapeutics, Inc. ("Vistagen" or the "Company") (NASDAQ: VTGN) and reminds investors of the March 16, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: Vistagen's positive assertions of fasedienol's future trial success based on the prior positive results associated with the PALISADE-2 clinical trial, in addition to notable enhancements and operational changes made to the execution of the PALISADE-3 clinical trial supported a strong likelihood of Phase 3 success and positioning it as a confirmatory study was false and misleading and/or concealing material adverse facts. This caused Plaintiff and other shareholders to purchase Vistagen's common stock at artificially inflated prices.

On December 17, 2025, before the market opened, Vistagen announced topline results from its PALISADE-3 Public Speaking Challenge Study of fasedienol for the acute treatment of social anxiety disorder (SAD). The company reported that the study failed to meet its primary efficacy endpoint since it "did not demonstrate statistically significant improvement on primary endpoint of reduction in anxiety as measured by SUDS scores compared to placebo."

Following this news, VTGN's stock price fell over 81% to open at $0.88 per share.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Vistagen's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Vistagen Therapeutics class action, go to www.faruqilaw.com/VTGN or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282883

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

ToplineAmazon on Thursday reported fourth-quarter earnings that fell below Wall Street’s estimates, sending shares of the e-commerce giant plummeting in after-hours trading following its earnings report that included a projection for a massive $200 billion in spending for 2026.

The e-commerce giant appeared to ramp up its AI strategy over the last year.

Copyright 2022 The Associated Press. All rights reserved.

Key FactsRevenue increased to $213.4 billion in Amazon’s latest quarter, beating consensus analyst estimates of $211.4 billion, according to FactSet, while $1.95 earnings per share fell below projections of $1.97 EPS.

Amazon CEO Andy Jassy said in a statement the company anticipated capital expenditures of $200 billion in 2026, citing “strong” demand for AI, chips, robotics and low-orbit satellites.

That’s well above consensus analyst estimates of $146.6 billion for capital expenditures.

Shares of Amazon dropped more than 7% as of 4:23 p.m. EST, after earlier diving by as much as 10% in extended trading.

Amazon’s revenue for 2025 reached $716.9 billion, beating projections of $714.6 billion, as Amazon Web Services revenue rose 20% year-over-year to $128.7 billion.

What Time Is Amazon’s Earnings Call?Amazon will host its Q4 earnings call at 5 p.m. EST, with an option to listen in on its investor relations website.

Key BackgroundAmazon’s stock dropped 5% over the last year, with the e-commerce giant’s heavy exposure to tariffs on China disrupting business throughout 2025. The company has moved to build out its AI offerings and cloud infrastructure, as competitors Microsoft and Google have rapidly increased spending to meet growing demand for AI products. Amazon has invested $8 billion in Anthropic, which announced updates to its AI agent that disrupted the global software market, rattling tech giants Oracle and Adobe, as well as India’s largest IT firms. Amazon last year opened an $11 billion AI data center exclusively for Anthropic to run workloads for its Claude chatbot. The company is also reportedly in talks to invest $50 billion in OpenAI, after earlier signing a $38 billion cloud computing deal with the startup in November. UBS analysts said in a note this week that they increased their estimates for Amazon’s capital expenditures, citing the company’s plans to grow its AWS business as Amazon became overshadowed by its megacap peers in the AI market.

What To Watch ForNvidia is the last of the “Magnificent Seven” companies to report quarterly earnings, which it will do on Feb. 25. Alphabet posted better-than-expected earnings on Wednesday, while Meta, Apple, Microsoft and Tesla reported last week.

Further ReadingForbesAlphabet Beats Earnings Expectations As Annual Revenue Tops $400 Billion For First TimeBy Ty RoushForbesMark Zuckerberg Passes Jeff Bezos For No. 4 Richest As Meta Stock Soars On Earnings BeatBy Ty Roush

New York, New York--(Newsfile Corp. - February 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BellRing Brands, Inc. (NYSE: BRBR) between November 19, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 23, 2026 lead plaintiff deadline.

SO WHAT: If you purchased BellRing securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the BellRing class action, go to https://rosenlegal.com/submit-form/?case_id=51444 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 23, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, BellRing develops, markets, and sells "convenient nutrition" products such as ready-to-drink ("RTD") protein shakes primarily under the brand name Premier Protein. During the Class Period, defendants represented that sales growth reflected increased end-consumer demand, attributing results to "organic growth," "distribution gains," "incremental promotional activity," and "[s]trong macro tailwinds around protein" among other factors. At the same time, defendants downplayed the impact of competition on demand, insisting BellRing was not experiencing any significant changes in competition, and that in the RTD category particularly, BellRing possessed a "competitive moat," given that "the ready-to-drink category is just highly complex" and the products are "hard to formulate." As alleged, in truth, BellRing's reported sales during the Class Period were driven by its key customers stockpiling inventory and did not reflect increased end-consumer demand or brand momentum. Following the destocking, BellRing admitted that competitive pressures were materially weakening demand. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the BellRing class action, go to https://rosenlegal.com/submit-form/?case_id=51444 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282929

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Q4: 2026-02-05 Earnings SummaryEPS of $3.42 beats by $0.02

 |

Revenue of

$4.36B

(10.26% Y/Y)

beats by $124.42M

IQVIA Holdings Inc. (IQV) Q4 2025 Earnings Call February 5, 2026 9:00 AM EST

Company Participants

Kerri Joseph - Senior VP of Investor Relations & Treasurer
Ari Bousbib - CEO & Chairman
Ronald Bruehlman - Executive VP & CFO
Michael Fedock - Senior Vice President of Financial Planning and Analysis

Conference Call Participants

Shlomo Rosenbaum - Stifel, Nicolaus & Company, Incorporated, Research Division
Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division
Justin Bowers - Deutsche Bank AG, Research Division
Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division
David Windley - Jefferies LLC, Research Division

Presentation

Operator

Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded.

Thank you. I would now like to turn the call over to Kerri Joseph, Senior Vice President, Investor Relations and Treasury. Mr. Joseph, please begin your conference.

Kerri Joseph
Senior VP of Investor Relations & Treasurer

Thank you, operator. Good morning, everyone. Thank you for joining our fourth quarter and full year 2025 earnings call. With me today are Ari Bousbib, Chairman and Chief Executive Officer, Ronald Bruehlman, Executive Vice President and Chief Financial Officer; Eric Sherbet, Executive Vice President and General Counsel; Mike Fedock, Senior Vice President, Financial Planning and Analysis; and Gustavo Perrone, Senior Director, Investor Relations.

Today, we'll be referencing a presentation that will be visible during this call for those of you on the webcast. This presentation will also be available following this call in the Events and Presentations section of our IQVIA Investor Relations website at ir.iqvia.com.

Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements. Actual results could differ materially from

Q3: 2026-02-04 Earnings SummaryEPS of $2.77 beats by $0.05

 |

Revenue of

$919.10M

(1.42% Y/Y)

misses by $13.03M

EnerSys (ENS) Q3 2026 Earnings Call February 5, 2026 9:00 AM EST

Company Participants

Lisa Langell - VP of Investor Relations & Corporate Communications
Shawn O'Connell - President, COO, President of Energy Systems Global & Director
Andrea Funk - Executive VP & CFO

Conference Call Participants

Noah Kaye - Oppenheimer & Co. Inc., Research Division
Alfred Moore - ROTH Capital Partners, LLC, Research Division
Brian Drab - William Blair & Company L.L.C., Research Division
Gregory Lewis - BTIG, LLC, Research Division

Presentation

Operator

Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today. At this time, I would like to welcome everyone to EnerSys' Q3 Fiscal '26 Earnings Webcast and Conference Call. [Operator Instructions] I would now like to turn the conference over to Lisa Langell, Vice President, Investor Relations and Corporate Communications. You may begin.

Lisa Langell
VP of Investor Relations & Corporate Communications

Good morning, everyone. Thank you for joining us today to discuss EnerSys fiscal third quarter results. On the call with me are Shawn O'Connell, EnerSys' President and Chief Executive Officer; and Andi Funk, EnerSys' Executive Vice President and Chief Financial Officer.

Last evening, we published our third quarter results with the SEC, which are available on our website. We also posted slides that we'll be referring to during this call. The slides are available on the Presentations page within the Investor Relations section of our website.

As a reminder, we will be presenting certain forward-looking statements on this call that are subject to uncertainties and changes in circumstances. Our actual results may differ materially from these forward-looking statements for a number of reasons. These statements are made only as of today. For a list of forward-looking statements and factors which could affect our future results, please refer to our recent Form 8-K and 10-Q

Unknown Attendee

As drug development teams finalize molecule optimization, packing development begins. Often a time-consuming process of evaluating multiple components, suppliers and test results. For prefilled syringes regulated as combination products, ambiguous requirements and extensive verification can add months to clinical time lines with no guarantee of full risk coverage.

Today's session introduces a new approach to prefillable syringe systems, a fully harmonized solution integrating the syringe barrel, plunger and a needle shield tip cap from a single verified supplier, West Pharmaceuticals. We will be led by Dr. Bettine Boltres, Director of Scientific Affairs, Integrated Systems with West. She will share how this integrated system reduces complexity, minimizes testing burden and enables emerging biotechnology companies to accelerate readiness for clinical fill while conserving time and resources.

I'm your host, James [indiscernible] with Pharmaceutical Online. I'd like to thank you, the audience, for attending today's event. This is live, so we do encourage your participation. Take a moment to get comfortable with the tools on your screen. Bettine's contact information is to your right. And below me, you'll see a question box. Please share your thoughts with us during the presentation. We will answer as many questions as possible. And any we miss, I'll pass along for follow-up after the event. This question box can connect you with me if you run into any trouble, but please try refreshing your browser first as it will fix most common issues.

Finally, today's event will be available on demand. You'll receive an e-mail with a shareable link shortly after we conclude.

Now without further ado, let's begin today's presentation. Welcome, Bettine.

ArcelorMittal S.A. (MT) Q4 2025 Earnings Call Transcript

Norfolk, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Virginia’s economy is facing increasing headwinds and growth in Hampton Roads is projected to slow according to the 2026 Annual Economic Forecast presented by economists from the Dragas Center for Economic Analysis and Policy in the Strome College of Business at Old Dominion University on January 28. 

More than 350 of the region’s business and community leaders gathered in Chartway Arena to hear how Bob McNab, Ph.D., professor and chair of the Department of Economics and director of the Dragas Center for Economic Analysis and Policy, and Vinod Agarwal, Ph.D., a professor of economics and director of the Economic Forecasting Project, view the economic prospects for the coming year. 

Rising inflation, consumer pessimism, slowed job growth, lack of housing inventory and the negative impacts of tariffs were primary topics of the event.

“Virginia’s economic growth was lower in 2025 due to reductions in federal civilian employment, higher tariffs and policy uncertainty,” said Dr. McNab.

He explained that, while some figures show the United States economy growing, the real story lies in the distribution of wealth. For households in the top 30% of consumers earning more than $130,000, wages and consumption outpaced inflation. The other 70% of consumers, however, are spending more than they are bringing in or just breaking even. 

“Moody’s (a financial intelligence company) says that Virginia is already in a recession. Data suggests that we may be on the cusp of one. Growth was slow in 2025 and will continue to slow in 2026. The impacts of changes in federal civilian employment policy, trade policy and immigration policy — all that comes together with policy uncertainty and strain growth in Virginia and make the budget conditions deteriorate as we move farther into this year,” he said. 

The rising prices of essential items, like electricity and coffee, are keeping consumer sentiment — a key indicator of the health of the economy — low, he added. The price of coffee, for instance, rose 20% in 2025. 

Employment figures were not promising. Employment growth, which had been on the rise, is now slowing, according to the Bureau of Labor Statistics. In 2025, over 6,000 federal civilian jobs were lost in Hampton Roads, and more than 23,000 were lost throughout Virginia. In October alone, the federal civilian workforce lost 179,000 workers nationally in the wake of the deferred resignation program. 

“We can see that Virginia actually starts shedding people out of the labor force in February 2025, and that continued through the remainder of the year. This looks much more like a recession for Virginia in terms of labor markets than anything else,” he said, pointing to a chart in his presentation. 

Employers are also becoming reticent about hiring, he said, noting that 2025 had the weakest job growth since the pandemic.

Dr. Agarwal discussed the Hampton Roads economy, focusing on the housing supply needs of the workforce and the outlook for the defense industry.

“The housing market has a supply problem. Inventories are way below the normal average. What we need to do is to develop a basic housing strategy and move towards reforming zoning regulations,” he said. “We need to promote high density, more mixed developments and reduce regulatory burdens that increase the cost of living.”

He said that defense spending in the area will rise, which is good for the Hampton Roads economy, but has a downside. 

“To really grow this economy, the private sector needs to step in,” he said. “We need to diversify the economy and go into areas of growth where there is a competitive advantage or where we see good potential.”

FRANKLIN, Ind.--(BUSINESS WIRE)--(OTCID: TDCB) - Third Century Bancorp (“Company”), the holding company for Mutual Savings Bank (“Bank”), announced it recorded unaudited net income of $550,000 for the quarter ended December 31, 2025, or $0.47 per basic and diluted share, compared to net income of $492,000 for the quarter ended December 31, 2024, or $0.42 per basic and diluted share. In addition, the Company recorded net income of $1,871,000 for the year ended December 31, 2025, or $1.61 per basic and diluted share, compared to net income of $1,312,000 for the year ended December 31, 2024, or $1.13 per basic and diluted share.

“We had a strong Q4 for 2025, following a solid prior nine-months,” stated David A. Coffey, President and CEO. Coffey continued, “We continued to see loan growth due to the efforts of our outstanding loan team. We also saw deposit growth due to our focus on core deposits in our market area. Our earnings were driven by our ability to capitalize on two important areas. First, non-interest income continues to be a strategic emphasis for the Bank. From general service charges to Trust Department fees, these were an important part of our fourth quarter performance. Second, our ability to be proactive in managing our cost of funding to positively impact our net interest margin was equally as important.” Coffey concluded, “As a result of a strong year, I am pleased to see key shareholder metrics improved.”

For the quarter ended December 31, 2025, net income increased $58,000, or 11.68%, to $550,000 as compared to $492,000 for the same period in the prior year. The increase in net income for the three-month period ended December 31, 2025, was driven primarily as a result of a $364,000 increase in net interest income as compared to the same period in the prior year. Net interest income increased to $2.39 million for the three months ended December 31, 2025, due to an increase in total interest income of $363,000, or 9.09%, to $4.35 million for the three-month period ended December 31, 2025, as compared to $3.99 million for the same period for the prior year. The increase in total interest income was due to an increase in average loan balances and average cash balances, as well as higher average yields on interest earning assets. Further contributing to net interest margin expansion, there was a decrease in total interest expense of $1,000, or 0.06%, to $1.97 million for the three-month period ended December 31, 2025, as compared to the same period for the prior year. The decrease in total interest expense was the result of reduced expense in retail deposits and lower average borrowing balances.

The provision for credit losses increased during the current quarter to $190,000 compared to a provision of $35,000 for the same quarter last year due to higher gross loan balances at quarter end and a slight increase in non-performing loans during the quarter.

Non-interest income for the quarter ended December 31, 2025, increased by $237,000, or 65.90%, to $597,000, as compared to $368,000 for the same period in the prior year. The increase in non-interest income occurred due to a higher volume of residential loan sales, increased Trust revenue, and service charge income as compared to the same period in the prior year. Non-interest expense increased by $392,000, or 21.90%, to $2,186,000 as compared to $1,794,000 for the same period in the prior year, due primarily to increased personnel expenses.

For the year ended December 31, 2025, net income increased $559,000, or 42.59%, to $1,871,000 as compared to $1,312,000 for the year ended December 31, 2024. The increase in net income for the year ended December 31, 2025, was due to several factors including an increase in total interest income, increased non-interest income, and a decrease in total interest expense. Net interest income increased by $1,083,000, or 13.80%, to $8,930,000 for the year ended December 31, 2025, as compared to $7,847,000 for the prior year. Net interest income increased due to an increase in total interest income of $922,000, or 5.87%, to $16,610,000 for the year ended December 31, 2025, as compared to $15,689,000 for the prior year. The increase in total interest income was due to higher average loan balances and higher interest-earning cash balances. Complementing the increase in total interest income was a decrease in total interest expense of $161,000, or 2.05%, to $7,681,000 for the year ended December 31, 2025, as compared to $7,842,000 for the prior year. The decrease in total interest expense was largely due to lower average wholesale borrowing balances. The provision for credit losses during 2025 was $204,000 compared to a provision credit of $15,000 for 2024, as a result of loan growth and a specific reserve for one borrower relationship. The loans comprising that relationship were subsequently paid off in January. Non-interest income increased by $368,000, or 27.82%, to $1,692,000 for the year ended December 31, 2025, as compared to $1,324,000 for the prior year. The increase was due largely to increased Trust revenue and a higher volume of loan sales on the secondary market. Non-interest expense increased by $500,000, or 6.37%, to $8,349,000 for the year ended December 31, 2025, as compared to $7,850,000 for the prior year. The increase in non-interest expense was primarily due to increased personnel expenses.

Total assets increased $36.81 million to $349.19 million at December 31, 2025, compared to $312.38 million at December 31, 2024. This increase was due primarily to higher levels of cash which increased by $24.66 million or 268.08% since December 31, 2024, and higher total loans. The increase in cash was due to growth in retail deposits. Gross loans held for investment rose by $13.05 million to $221.49 million at December 31, 2025, compared to $208.44 million at December 31, 2024. Total deposits were $280.09 million at December 31, 2025, up from $240.99 million at December 31, 2024. FHLB advances decreased by $6.0 million or 11.76% to $45.0 million at December 31, 2025, from $51.0 million at December 31, 2024. As of December 31, 2025, the weighted average rate of all FHLB advances was 3.75% compared to 3.81% at December 31, 2024, and the weighted average maturity was 3.97 years at December 31, 2025, compared to 4.20 years at December 31, 2024.

Stockholders’ equity was $13.17 million at December 31, 2025, compared to $9.46 million at December 31, 2024. Stockholders’ equity increased due to retained net income for the year as well as a decrease in net unrealized loss of $2,082,000 during the twelve months ended December 31, 2025, as a result of the increase in the fair value of our available- for-sale-securities due to the improvement in the forward rate curve compared to our portfolio at prior year end. The available-for-sale securities are investments in government sponsored mortgage-backed securities as well as investments in municipal bonds, which provide cash flow for business purposes. Quarterly average equity as a percentage of average assets increased to 3.69% at December 31, 2025, compared to 3.27% at December 31, 2024.

Founded in 1890, Mutual Savings Bank is a full-service financial institution based in Johnson County, Indiana. In addition to its main office at 80 East Jefferson Street, Franklin, Indiana, the Bank operates branches in Franklin at 1124 North Main Street, Trafalgar and Greenwood, Indiana.

This press release contains certain forward-looking statements that are based on assumptions and may describe future plans, strategies and expectations of the Company. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. They often include words like “believe,” “expect,” “anticipate,” “estimate” and “intend” or future or conditional verbs such as “will,” “would,” “should,” “could” or “may.” Certain factors that could cause actual results to differ materially from expected results include inflation, tariffs, changes in the interest rate environment, changes in general economic conditions, geopolitical conflicts, public health issues, legislative and regulatory changes that adversely affect the business of the Company and the Bank, and changes in the securities markets. Except as required by law, the Company does not undertake any obligation to update any forward-looking statements to reflect changes in belief, expectations, or events.

Condensed Consolidated Statements of Income

(Unaudited)

In thousands, except per share data

  Three Months Ended Twelve Months Ended December 31, September 30, December 31, December 31, December 31, 2025

2025

2024

2025

2024

Selected Consolidated Earnings Data: Total Interest Income $

4,352

$

4,289

$

3,989

$

16,610

$

15,689

Total Interest Expense 1,965

2,027

1,966

7,681

7,842

Net Interest Income 2,387

2,262

2,023

8,930

7,847

Provision/(Credit) for Losses 190

27

35

204

(15

)

Net Interest Income after Provision for Losses 2,197

2,235

1,988

8,726

7,862

Non-Interest Income 597

368

360

1,692

1,324

Non-Interest Expense 2,186

2,074

1,794

8,349

7,850

Income Tax Expense 58

31

62

198

24

Net Income $

550

$

498

$

492

$

1,871

$

1,312

  Earnings Per Share - basic $

0.47

$

0.43

$

0.42

$

1.61

$

1.13

Earnings Per Share - diluted $

0.47

$

0.42

$

0.42

$

1.61

$

1.13

Condensed Consolidated Balance Sheet

(Unaudited)

In thousands, except per share data

  December 31, September 30, December 31, 2025

2025

2024

Selected Consolidated Balance Sheet Data: Assets Cash and Due from Banks $

33,865

$

41,283

$

9,200

Investment Securities, Available-for-Sale, at Fair Value 72,118

71,461

72,739

Investment Securities, Held-to-Maturity 2,950

2,950

2,950

Loans Held-for-Sale -

2,102

67

Loans Held-for-Investment 221,485

212,353

208,438

Allowance for Credit Losses 3,157

2,968

2,962

Net Loans Held-for-Investment 218,327

209,385

205,477

Accrued Interest Receivable 1,641

1,507

1,524

Other Assets 20,287

20,274

20,419

Total Assets $

349,188

$

348,963

$

312,376

  Liabilities Noninterest-Bearing Deposits $

46,543

$

45,449

$

40,362

Interest-Bearing Deposits 233,543

222,819

200,626

Total Deposits 280,086

268,268

240,988

FHLB Advances and Other Borrowings 45,000

58,000

51,000

Subordinated Notes, Net of Issuances Costs 9,812

9,805

9,785

Accrued Interest Payable 472

404

527

Accrued Expenses and Other Liabilities 645

778

618

Total Liabilities 336,016

337,256

302,918

Stockholders' Equity Common Stock 11,475

11,475

11,480

Retained Earnings 13,056

12,565

11,418

Accumulated Other Comprehensive Gain/(Loss) (11,358

)

(12,332

)

(13,440

)

Total Stockholders' Equity 13,173

11,708

9,457

Total Liabilities and Stockholders' Equity $

349,188

$

348,963

$

312,376

Three Months Ended Twelve Months Ended dollar figures are in thousands, except per share data December 31, September 30, December 31, December 31, December 31, 2025

2025

2024

2025

2024

Selected Financial Ratios and Other Data (Unaudited): Interest Rate Spread During Period 2.48

%

2.44

%

2.21

%

2.45

%

2.04

%

Net Yield on Interest-Earning Assets 5.33

%

5.43

%

5.31

%

5.36

%

5.21

%

Non-Interest Expense, Annualized, to Average Assets 2.54

%

2.49

%

2.27

%

2.55

%

2.48

%

Return on Average Assets, Annualized 0.64

%

0.60

%

0.62

%

0.57

%

0.41

%

Return on Average Equity, Annualized 17.33

%

21.09

%

19.03

%

18.27

%

13.93

%

Average Equity to Assets 3.69

%

2.83

%

3.27

%

3.13

%

2.97

%

  Average Net Loans $

213,412

$

209,332

$

204,241

$

208,732

$

198,323

Average Net Securities 74,922

72,569

77,644

74,069

79,535

Average Other Interest-Earning Assets 38,225

34,124

18,528

27,297

23,230

Total Average Interest-Earning Assets 326,560

316,024

300,413

310,098

301,088

Average Total Assets 344,011

333,492

316,650

327,186

317,006

  Average Noninterest-Bearing Deposits $

44,809

$

41,330

$

41,328

$

41,716

$

41,107

Average Interest-Bearing Deposits 225,140

213,636

202,162

211,263

204,530

Average Total Deposits 269,949

254,966

243,490

252,979

245,637

Average Wholesale Funding 50,446

58,000

51,734

53,132

42,786

Average Interest-Bearing Liabilities 275,586

271,636

253,896

264,395

247,316

  Avg. Interest-Earnings Assets to Avg. Interest-Bearings Liabilities 118.50

%

116.34

%

118.32

%

117.29

%

121.74

%

Average equity $

12,684

$

9,442

$

10,343

$

10,239

$

9,419

Non-Performing Loans to Gross Loans Held-for-Investment 0.17

%

0.00

%

0.88

%

0.18

%

0.88

%

Allowance for Credit Losses to Total Loans Outstanding 1.43

%

1.40

%

1.42

%

1.43

%

1.42

%

Allowance for Credit Losses to Non-Performing Loans 858.01

%

0.00

%

161.85

%

858.01

%

161.85

%

Net Loan Chargeoff/(Recovery) to Avg. Total Loans Outstanding -0.01

%

-0.01

%

0.00

%

-0.01

%

0.00

%

Effective Income Tax Rate 9.48

%

5.85

%

11.17

%

9.56

%

1.80

%

Tangible Book Value Per Share $

11.27

$

10.02

$

8.14

$

11.27

$

8.14

Market Closing Price at the End of Quarter $

9.35

$

9.45

$

9.03

$

9.35

$

9.03

Price-to-Tangible Book Value 82.94

%

94.31

%

110.91

%

82.94

%

110.91

%

HomeIndustriesInternet/Online ServicesThe Ratings GameThe Ratings GameUber’s stock has fallen more than 20% off peak levels due to concerns about costly futuristic plans, but Deutsche Bank analysts say the investments are worthwhilePublished: Feb. 5, 2026 at 3:30 p.m. ET

Uber Technologies is investing heavily in autonomous vehicles and other areas for long-term growth. That’s been a sore point for investors worried about profits in the here and now.

“We suspect everyone believed there should have been more Ebitda upside,” Benchmark analyst Daniel Kurnos wrote Thursday, referring to earnings before interest, taxes, depreciation and amortization. Instead, results on that profit metric Wednesday were more in line with the consensus view last quarter, and the company’s forecast for the first quarter of 2026 narrowly missed Wall Street’s expectations.

Shares in Alphabet Inc. are tracking lower following the release of its Q4 results. GOOGL's results were positive, and the management team provided a positive outlook that included significant AI spending. I believe the declines are a healthy pause following a nearly 70% gain over the last six months.

With its biggest intraday drop in months immediately followed by its biggest intraday gain, Sandisk Corporation NASDAQ: SNDK has entered a new phase of price action. The stock had already been crowned one of the standout winners of 2025 before adding nearly 200% in the first few weeks of 2026.